| A high-resolution in vivo atlas of the human brain's serotonin system V Beliveau, M Ganz, L Feng, B Ozenne, L Højgaard, PM Fisher, C Svarer, ... Journal of Neuroscience 37 (1), 120-128, 2017 | 412 | 2017 |
| Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels MK Madsen, PM Fisher, D Burmester, A Dyssegaard, DS Stenbæk, ... Neuropsychopharmacology 44 (7), 1328-1334, 2019 | 395 | 2019 |
| The precision–recall curve overcame the optimism of the receiver operating characteristic curve in rare diseases B Ozenne, F Subtil, D Maucort-Boulch Journal of clinical epidemiology 68 (8), 855-859, 2015 | 301 | 2015 |
| A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding MK Madsen, PMD Fisher, DS Stenbæk, S Kristiansen, D Burmester, ... European Neuropsychopharmacology 33, 71-80, 2020 | 147 | 2020 |
| A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain NR Raval, A Johansen, LL Donovan, NF Ros, B Ozenne, HD Hansen, ... International journal of molecular sciences 22 (2), 835, 2021 | 146 | 2021 |
| Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study L Staerk, EL Fosbøl, GYH Lip, M Lamberts, AN Bonde, C Torp-Pedersen, ... European heart journal 38 (12), 907-915, 2017 | 119 | 2017 |
| Standard and reduced doses of dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study L Staerk, TA Gerds, GYH Lip, B Ozenne, AN Bonde, M Lamberts, ... Journal of internal medicine 283 (1), 45-55, 2018 | 113 | 2018 |
| riskRegression: predicting the risk of an event using Cox regression models B Ozenne, AL Sørensen, T Scheike, C Torp-Pedersen, TA Gerds The R Journal 9 (2), 440-460, 2017 | 90 | 2017 |
| Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience MK Madsen, DS Stenbæk, A Arvidsson, S Armand, ... European Neuropsychopharmacology 50, 121-132, 2021 | 83 | 2021 |
| riskRegression: risk regression models and prediction scores for survival analysis with competing risks TA Gerds, B Ozenne R package version 5, 2020, 2020 | 67 | 2020 |
| Psilocybin-induced mystical-type experiences are related to persisting positive effects: a quantitative and qualitative report DEW McCulloch, MZ Grzywacz, MK Madsen, PS Jensen, B Ozenne, ... Frontiers in pharmacology 13, 841648, 2022 | 65 | 2022 |
| The net chance of a longer survival as a patient-oriented measure of treatment benefit in randomized clinical trials J Péron, P Roy, B Ozenne, L Roche, M Buyse JAMA oncology 2 (7), 901-905, 2016 | 65 | 2016 |
| Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans DS Stenbæk, MK Madsen, B Ozenne, S Kristiansen, D Burmester, ... Journal of Psychopharmacology 35 (4), 459-468, 2021 | 63 | 2021 |
| An extension of generalized pairwise comparisons for prioritized outcomes in the presence of censoring J Péron, M Buyse, B Ozenne, L Roche, P Roy Statistical methods in medical research 27 (4), 1230-1239, 2018 | 60 | 2018 |
| On the estimation of average treatment effects with right‐censored time to event outcome and competing risks BMH Ozenne, TH Scheike, L Stærk, TA Gerds Biometrical Journal 62 (3), 751-763, 2020 | 59 | 2020 |
| Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals DEW McCulloch, MK Madsen, DS Stenbaek, S Kristiansen, B Ozenne, ... Journal of Psychopharmacology 36 (1), 74-84, 2022 | 52 | 2022 |
| Molecular imaging of neuroinflammation in patients after mild traumatic brain injury: a longitudinal 123I‐CLINDE single photon emission computed tomography study SE Ebert, P Jensen, B Ozenne, S Armand, C Svarer, DS Stenbaek, ... European Journal of Neurology 26 (12), 1426-1432, 2019 | 50 | 2019 |
| Blood–brain barrier permeable β-blockers linked to lower risk of Alzheimer’s disease in hypertension EE Beaman, AN Bonde, SMU Larsen, B Ozenne, TJ Lohela, ... Brain 146 (3), 1141-1151, 2023 | 47 | 2023 |
| Predicting treatment outcome in major depressive disorder using serotonin 4 receptor PET brain imaging, functional MRI, cognitive-, EEG-based, and peripheral biomarkers: a … K Köhler-Forsberg, A Jorgensen, VH Dam, DS Stenbæk, PM Fisher, CT Ip, ... Frontiers in psychiatry 11, 641, 2020 | 43 | 2020 |
| Pre-intervention test-retest reliability of EEG and ERP over four recording intervals CT Ip, M Ganz, B Ozenne, LB Sluth, M Gram, G Viardot, P l'Hostis, ... International Journal of Psychophysiology 134, 30-43, 2018 | 43 | 2018 |
